Clinical Trial Update: Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating MRI with hyperpolarized 13C-pyruvate as a diagnostic tool for advanced prostate cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Ivan de Kouchkovsky, MD | Conditions: Prostate Cancer, Advanced Prostate Carcinoma | Phase 2 | Status: RECRUITING